• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy
CONCLUSION: RAS inhibitors are preferred for the treating hypertension and improving CV outcomes in patients with hypertension and breast cancer undergoing DOX-containing chemotherapy, particularly in patients with comorbid diabetes. However, CCBs are equivalent to RAS inhibitors and are more favorable than BBs and TDs in terms of improving CV outcomes.PMID:37704380 | DOI:10.4048/jbc.2023.26.e34
Source: Journal of Breast Cancer - September 13, 2023 Category: Cancer & Oncology Authors: Hui-Jeong Hwang Sang-Ah Han Source Type: research

Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials
ConclusionIntravenous beta-blockers improved the MSI, decreased the risk of VT/VF in the first 24 h, and were associated with increased LVEF at 1 week and 6 months following PCI. In particular, intravenous beta-blockers started before PCI is beneficial for patients with LAD lesions.
Source: Cardiovascular Drugs and Therapy - April 1, 2023 Category: Cardiology Source Type: research

Association of Beta Blockers and Calcium Channel Blockers with Arrhythmia After Carotid Intervention
Postoperative arrhythmia has a reported incidence of 2% to 4%, which can increase patients ’ risk of developing stroke or myocardial infarction; however, insufficient data are available regarding the prognostic implications and management of arrhythmia after carotid intervention. The aim of this study was to identify the factors associated with arrhythmia after carotid intervention usin g data collected as a part of the Society for Vascular Surgery Vascular Quality Initiative.
Source: Journal of Vascular Surgery - March 17, 2023 Category: Surgery Authors: Teah Qvavadze, Fedor Lurie, Todd Russell Source Type: research

Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies
AbstractAtrial fibrillation (AF) is an increasingly common arrhythmia encountered in clinical practice that leads to a substantial increase in utilization of healthcare services and a decrease in the quality of life of patients. The prevalence of AF will continue to increase as the population ages and develops cardiac comorbidities; thus, prompt and effective treatment is important to help mitigate systemic resource utilization. Treatment of AF involves two tenets: prevention of stroke and systemic embolism and symptom control with either a rate or a rhythm control strategy. Historically, due to the safe nature of medicati...
Source: American Journal of Cardiovascular Drugs - March 30, 2022 Category: Cardiology Source Type: research

Case Report of High-Grade Atrioventricular Block and Takotsubo Cardiomyopathy
CONCLUSION: When AVB or other arrhythmias initiate a TTC, the patient can experience sudden cardiac death and decompensate quickly. Therefore, clinicians should understand this rare but fatal complication because these patients require pacemakers and beta blockers.PMID:35348088 | PMC:PMC8817916 | DOI:10.7812/TPP/21.006
Source: The Permanente journal - March 29, 2022 Category: General Medicine Authors: Rohan Prasad Mohammad Fahad Salam Shaurya Srivastava Fnu Samreen Zulfiqar Qutrio Baloch Source Type: research

Pages: 1  2  3